Pharmaceutical Analysis & Statistics in Japan, December 2012 (p30)

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: therapeutics, drug, cancer, more »

871-900 of about 1 700 reports

Purchase Reports From Reputable Market Research Publishers

Other Hematological Disorders - Pipeline Review, H2 2012

Other Hematological Disorders - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • December 2012
  • by Global Markets Direct

Other Hematological Disorders - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Other Hematological Disorders - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : Japan, World
Diabetic Neuropathic Pain - Pipeline Review, H2 2012

Diabetic Neuropathic Pain - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • December 2012
  • by Global Markets Direct

Diabetic Neuropathic Pain - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Diabetic Neuropathic Pain - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Therapy
  • Countries : Japan, World
Therapy in Japan: Japanese Encephalitis - Pipeline Review, H2 2011

Therapy in Japan: Japanese Encephalitis - Pipeline Review, H2 2011

  • $ 2 000
  • Company report
  • December 2012
  • by Global Markets Direct

Bacterial Conjunctivitis - Pipeline Review, H2 2011 Global Industries Direct's, 'Bacterial Conjunctivitis - Pipeline Review, H2 2011', provides an overview of the Bacterial Conjunctivitis therapeutic pipeline. ...

  • Industries : Drug and Medication
  • Countries : Japan
Pancreatitis - Pipeline Review, H2 2012

Pancreatitis - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • December 2012
  • by Global Markets Direct

Pancreatitis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Pancreatitis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World, Japan
Orphan Drugs: Market Environment Products and Companies

Orphan Drugs: Market Environment Products and Companies

  • $ 1 566
  • Industry report
  • December 2012
  • by Espicom Business Intelligence

The combination of government incentives to develop drugs for rare diseases and the promise of commercial opportunity will continue to fuel the industry's interest in orphan drugs; and provide hope to ...

  • Industries : Drug and Medication
  • Countries : United States, Australia, Japan, Sweden
Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

  • $ 3 500
  • Industry report
  • December 2012
  • by GBI Research

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Summary GBI Research, the leading business intelligence ...

  • Industries : Generic Drug
  • Countries : Europe, United States, World, Japan, Spain, Italy, France, Germany
OTC Medications - Japan   (2012)

OTC Medications - Japan (2012)

  • $ 599
  • Industry report
  • December 2012
  • by Mintel

OTC Medications in Japan by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, ...

  • Industries : Over-the-counter Drug
  • Countries : Japan
Vitamins & Minerals - Japan   (2012)

Vitamins & Minerals - Japan (2012)

  • $ 599
  • Industry report
  • December 2012
  • by Mintel

Vitamins & Minerals in Japan by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers single/dual, multi-vitamins and minerals. ...

  • Industries : Vitamin and Supplement
  • Countries : Japan
Merger and Acquisition Terms and Agreements

Merger and Acquisition Terms and Agreements

  • $ 2 995
  • Company report
  • December 2012
  • by Currentpartnering

Summary The Merger and Acquisition Terms and Agreements report provides comprehensive understanding and unprecedented access to the M&A deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Pharmaceutical
  • Countries : Japan
Pharmaceuticals - Global Group of Eight (G8) Industry Guide, MarketLine Industry Guides

Pharmaceuticals - Global Group of Eight (G8) Industry Guide, MarketLine Industry Guides

  • $ 1 495
  • Industry report
  • December 2012
  • by MarketLine Industry Guides

Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, ...

  • Industries : Pharmaceutical
  • Countries : United States, United Kingdom, Canada, Russian Federation, Italy, France, Germany, Japan, World, Europe
Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides

Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides

  • $ 1 495
  • Industry report
  • December 2012
  • by MarketLine Industry Guides

Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals: Global Industry Guide industry. It includes detailed data on market size and ...

  • Industries : Pharmaceutical
  • Countries : World, United States, United Kingdom, Netherlands, Europe, France, Germany, Japan, Canada, Spain, Italy, Belgium, China
Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides

Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides

  • $ 1 495
  • Industry report
  • December 2012
  • by MarketLine Industry Guides

Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals: Global Industry Guide industry. It includes detailed data on market size and ...

  • Industries : Pharmaceutical
  • Countries : World, United States, United Kingdom, Netherlands, Europe, France, Germany, Japan, Canada, Spain, Italy, Belgium, China
Pharmaceuticals - Global Group of Eight (G8) Industry Guide, MarketLine Industry Guides

Pharmaceuticals - Global Group of Eight (G8) Industry Guide, MarketLine Industry Guides

  • $ 1 495
  • Industry report
  • December 2012
  • by MarketLine Industry Guides

Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, ...

  • Industries : Pharmaceutical
  • Countries : United States, United Kingdom, Canada, Russian Federation, Italy, France, Germany, Japan, World, Europe
PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis

PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • November 2012
  • by Global Data

PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast ...

  • Industries : Drug and Medication
  • Countries : Japan
PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis Event-Driven Update

  • $ 4 995
  • Industry report
  • November 2012
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new Country report, ?PharmaPoint: Rheumatoid Arthritis - Japan Drug ...

  • Industries : Pathology
  • Countries : Japan
Hisamitsu Pharmaceutical Co., Inc.: Company Capsule

Hisamitsu Pharmaceutical Co., Inc.: Company Capsule

  • $ 99
  • Company report
  • November 2012
  • by Canadean Ltd

Synopsis Canadean's "Hisamitsu Pharmaceutical Co., Inc. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, ...

  • Industries : Drug and Medication
  • Countries : Japan
Taiko Pharmaceutical Co.,Ltd.: Company Capsule

Taiko Pharmaceutical Co.,Ltd.: Company Capsule

  • $ 99
  • Company report
  • November 2012
  • by Canadean Ltd

Synopsis Canadean's "Taiko Pharmaceutical Co.,Ltd. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, majo ...

  • Industries : Pharmaceutical
  • Countries : Japan
Mikasa Seiyaku Co., Ltd.: Company Capsule

Mikasa Seiyaku Co., Ltd.: Company Capsule

  • $ 99
  • Company report
  • November 2012
  • by Canadean Ltd

Synopsis Canadean's "Mikasa Seiyaku Co., Ltd. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products ...

  • Industries : Prescription Drug
  • Countries : Japan
EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022

EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • November 2012
  • by Global Data

EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022 Summary Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such ...

  • Industries : Drug and Medication
  • Countries : Japan, India, China, United States, United Kingdom, Spain, Italy, Germany, France, World, Europe, Asia
Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom
Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis

Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Japan, Australia, United States, Spain, Italy, France, Germany, World, Europe, United Kingdom
Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Australia, Czech Republic, United States, Spain, Italy, France, Germany, Japan, World, Europe, United Kingdom
Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Australia, World, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom, India
Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis

Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, India, China, United States, Europe, United Kingdom
Humira (Rheumatoid Arthritis) Forecast and Market Analysis

Humira (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Humira (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Humira (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom
Remicade (Rheumatoid Arthritis) Forecast and Market Analysis

Remicade (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Remicade (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Remicade (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, India, China, United States, Europe, United Kingdom
Simponi (Rheumatoid Arthritis) Forecast and Market Analysis

Simponi (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Simponi (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Simponi (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom
Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis

Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom
Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis

Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Japan, Australia, United States, Spain, Italy, France, Germany, World, Europe, United Kingdom
Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis

Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Company report
  • November 2012
  • by Global Data

Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom

31 Companies

Read our Company Profiles

Icon Group

United States

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.